Teva Launches New Generic FazaClo Strengths

Teva announced the launch of two new strengths of Clozapine ODT (orally disintegrating tablets), the generic version of Jazz Pharmaceutical’s FazaClo.

Clozapine ODT is an atypical antipsychotic indicated for the treatment of treatment-resistant schizophrenia and to reduce suicidal behavior in patients with schizophrenia or schizoaffective disorder in adults.

RELATED: Atypical Antipsychotic Pharmacokinetics

Clozapine ODT will now be offered as 150mg and 200mg strength orally disintegrating tablets in 100-count bottles. It is also available as 12.5mg, 25mg, and 100mg strength orally disintegrating tablets.

For more information call (888) 838-2872 or visit